WS Kim Announced President, GE Healthcare Korea
WS Kim will work with CW Lee and play a leading role in driving organic growth in Korea by developing and executing on a strategy to create new markets and increase market shares for the diagnostic imaging business.
WS Kim joined GE International Korea as Finance Director in 1999 and has moved to GE Medical Systems Korea in 2001 to assume the role of CFO. He then took on roles such as the Master Black Belt for Asia Growth Markets and Service Manager of GE Healthcare Korea, proving himself as the next generation leader of GE.
On his appointment, WS Kim commented, “We will achieve growth with the customers by providing innovative diagnostic imaging technology and differentiated digital services to local healthcare professionals that maintain high global competitiveness,” and added, “through GE Healthcare’s capabilities in providing comprehensive solution across genetic engineering, diagnostics medicine and pharmaceuticals, I hope to help the local healthcare industry lead in terms of early health services, which is a futuristic healthcare model that aims to detect and treat diseases before they show symptoms.”
Meanwhile, GE Healthcare Asia Growth Markets president CW LEE stated, “Korea has a thriving healthcare market that currently witnesses significant demographic changes and strong demand on healthcare infrastructure, technology and expertise. We expect WS Kim to meet the growing needs of this dynamic region through his extensive knowledge of the marketplace combined with a clear strategy and commitment to our customers.”
WS Kim received his bachelors and masters degree in Business Administration at Yonsei University and obtained an MBA from Indiana University. Prior to GE, he has worked at Korea Life Insurance as an analyst and at An Kwon Accounting Firm as a CPA. He is a certified public accountant.
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.
GE Healthcare’s broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future Is to enable a new “early health” model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a USD 17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and other patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
웹사이트: http://www.gehealthcare.com
연락처
News Communications 6323-5000
Sumi Kim 011-1796-7580
Heidi Kim 016-752-7977
Carmen Lee 011-388-8217
이 보도자료는 GE Healthcare가(이) 작성해 뉴스와이어 서비스를 통해 배포한 뉴스입니다. 뉴스와이어는 편집 가이드라인을 준수합니다.
